Javascript must be enabled to continue!
A Resource to Acquire and Summarize Pharmacogenetics Knowledge in the Literature
View through CrossRef
To determine how genetic variations contribute the variations in drug response, we need to know the genes that are related to drugs of interest. But there are no publicly available databases of known gene-drug relationships, and it is time-consuming to search the literature for this information. We have developed a resource to support the storage, summarization, and dissemination of key gene-drug interactions of relevance to pharmacogenetics. Extracting all gene-drug relationships from the literature is a daunting task, so we distributed a tool to acquire this knowledge from the scientific community. We also developed a categorization scheme to classify gene-drug relationships according to the type of pharmacogenetic evidence that supports them. Our resource (http://www.pharmgkb.org/home/project-community.jsp) can be queried by gene or drug, and it summarizes gene-drug relationships, categories of evidence, and supporting literature. This resource is growing, containing entriesfor 138 genes and 215 drugs of pharmacogenetics significance, and is a core component of PharmGKB, a pharmacogenetics knowledge base (http://www.pharmgkb.org).
Title: A Resource to Acquire and Summarize Pharmacogenetics Knowledge in the Literature
Description:
To determine how genetic variations contribute the variations in drug response, we need to know the genes that are related to drugs of interest.
But there are no publicly available databases of known gene-drug relationships, and it is time-consuming to search the literature for this information.
We have developed a resource to support the storage, summarization, and dissemination of key gene-drug interactions of relevance to pharmacogenetics.
Extracting all gene-drug relationships from the literature is a daunting task, so we distributed a tool to acquire this knowledge from the scientific community.
We also developed a categorization scheme to classify gene-drug relationships according to the type of pharmacogenetic evidence that supports them.
Our resource (http://www.
pharmgkb.
org/home/project-community.
jsp) can be queried by gene or drug, and it summarizes gene-drug relationships, categories of evidence, and supporting literature.
This resource is growing, containing entriesfor 138 genes and 215 drugs of pharmacogenetics significance, and is a core component of PharmGKB, a pharmacogenetics knowledge base (http://www.
pharmgkb.
org).
Related Results
Pharmacogenetics
Pharmacogenetics
Abstract
Pharmacogenetics (PGt) is the study of the influence of individual variations in
deoxyribonucleic acid
...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Ivan Illich, Iatrogenesis and Pharmacogenetics
Ivan Illich, Iatrogenesis and Pharmacogenetics
In Medical Nemesis - The expropriation of health, IVAN ILLICH highlights several aspects of the medicalization of society, which was already observed in the mid-1970s. He addressed...
KNOWLEDGE IN PRACTICE
KNOWLEDGE IN PRACTICE
Knowledge is an understanding of someone or something, such as facts, information, descriptions or skills, which is acquired by individuals through education, learning, experience ...
Pharmacogenetics: Therapeutic regimen in hypertension
Pharmacogenetics: Therapeutic regimen in hypertension
Pharmacogenetics in hypertension is a field of study that aims to understand how interindividual genetic variability can influence the response to medications used to treat high bl...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Establishing the Genotyping Method for NAT2 Polymorphism in Vietnamese Tuberculoma Patients
Establishing the Genotyping Method for NAT2 Polymorphism in Vietnamese Tuberculoma Patients
The metabolism of Isoniazid, one of the first-line antituberculosis drugs for TB treatment and prophylaxis, depends on the acetyltransferase 2 acetylation (NAT2) phenotype. Differe...

